Page 95 - Eceptor News Today

A scientific breakthrough by Tel Aviv University: A team of researchers from the university has demonstrated that antibodies isolated from the immune system of recovered COVID-19 patients are effective in neutralizing all known strains of the virus, including the Delta and the Omicron variants.

Researchers reviewed the epidemiology, clinical character, treatment, and prevention of human monkeypox.

A newly developed agonistic antibody reduced the amyloid pathology in mice with Alzheimer's disease, signaling its promise as a potential treatment for the disease, according to a team of researchers at UTHealth Houston.

Researchers review current knowledge regarding the generation of immune memory responses and their durability post-infection and vaccination.

Researchers developed an αRep series specific to the RBD of the SARS-CoV-2 S, which could easily adapt to work stably against SARS-CoV-2 variants at a low cost.

In a recent review published in the journal Endocrines, researchers summarized existing literature findings on the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on the male reproductive system and fertility.

Researchers evaluated immune responses by B lymphocytes to Pfizer’s severe acute respiratory syndrome coronavirus 2 mRNA vaccine.

Scientists have discovered a new protein which helps sperm fuse to an egg and is fundamental for human fertilization.

Scientists have recently reviewed research articles related to the application of inorganic nanoparticles in delivering drugs to the brain through the intranasal route.

Researchers demonstrated the production of nanobodies against SARS-CoV-2 spike protein.